WednesdayJun 14, 2017 3:48 pm

AzurRx BioPharma, Inc. (NASDAQ: AZRX) is “One to Watch”

With more than a century of combined experience spanning the gamut from pancreas/GI tract issues in hepato-gastroenterology and infectious disease to the development of novel non-systemic (localized) therapeutic biologics and proteomics (protein engineering), the AzurRx BioPharma, Inc. (NASDAQ: AZRX) core science team is the real strength behind the company’s developing portfolio of recombinant therapies. AzurRx has come quite a long way on the strength of its science-driven approach and today stands tall upon the IP foundation of its two main pipeline programs. The lead candidate of which, MS1819 lipase, is currently in ongoing, open-label Phase IIa trials in EPI (exocrine…

Continue Reading

WednesdayJun 14, 2017 1:43 pm

Epazz’s (EPAZ) Unique Web-Based Software Platform Offering Enhanced Communication and Information Opportunities

Leading cloud-based software company Epazz, Inc. (OTC: EPAZ) is revolutionizing the way integrated web-based applications work by offering one of the most comprehensive and unique software packages available on the market, with the ultimate goal of enhancing the way businesses and institutions operate. The company’s flagship product, BoxesOS web portal infrastructure system, includes a wide range of integration features with enhanced compatibility with several back-end systems and a multitude of customization options for the end users. Founded in 1999 by Shaun Passley, current chairman and CEO, Epazz specializes in offering customized web applications and integration to the corporate world, but…

Continue Reading

WednesdayJun 14, 2017 1:29 pm

CD International Enterprises, Inc. (CDII) Turning Logistical Capability into Copper and Crystal

What’s the connection, you may ask, between copper and cannabidiol (CBD) crystal, both of which are in the offing to be marketed by CD International Enterprises, Inc. (OTC: CDII). The Florida-based corporation recently signed contracts with suppliers of those commodities and other minerals and plans to target markets in the U.S. and within Chinese-speaking communities around the globe. The nexus in this web of distribution is the company’s logistical savvy. After a decade of shipping a variety of industrial materials around the world, CD International Enterprises knows more than a thing or two about procurement and distribution. CDII cut its…

Continue Reading

WednesdayJun 14, 2017 11:36 am

QualityStocksNewsBreaks – ORHub, Inc. (ORHB) Announces Launch of New Service Module Targeting Hip and Knee Surgical Procedures

Health care software-as-a-service company ORHub, Inc. (OTC: ORHB) today announced the planned launch of its new service module for hip and knee surgical procedures, which is scheduled to take place in July 2017. “The launch of this new module follows the successful launch of our spine module, which for the past eight months has been in continuous use in two nationally recognized hospitals, achieving overwhelming success,” Colt Melby, CEO of ORHub, stated in the news release. “Our hips and knees module is the second of many on our technical road map that will allow us to exponentially grow our addressable…

Continue Reading

WednesdayJun 14, 2017 9:30 am

QualityStocksNewsBreaks – ChineseInvestors.com, Inc. (CIIX) Targets Canadian Cannabis Market by Incorporating CBD Biotechnology Inc. in British Columbia

Market analysis company ChineseInvestors.com, Inc. (OTCQB: CIIX) this morning announced that it has incorporated CBD Biotechnology Inc. in British Columbia, Canada. “I am delighted about the incorporation of CBD Biotechnology Inc.,” Warren Wang, founder and CEO of CIIX, stated in the news release. “The incorporation of CBD Biotechnology Inc. is a promising step forward towards CIIX's goals to enter the medical marijuana industry. Through its expansion into Canada, CIIX aims generate significant revenues through sales of CBD-based health products, while helping the nearly one million Chinese in Canada to improve their overall health.” Canada promises to play a major role…

Continue Reading

TuesdayJun 13, 2017 2:19 pm

Significant Milestones Put Player’s Network (PNTV) on the Radar

It’s been an exciting few months for Player’s Network, Inc. (OTCQB: PNTV), and the markets have reacted with increased interest in this active diversified holding company, which recently recorded its first revenues (http://dtn.fm/GN3dT), received its state-issued medical marijuana licenses (http://dtn.fm/g69W7), and commenced operations at its 27,000-square-foot marijuana facility in North Las Vegas. These and other major milestones achieved so far in 2017 make PNTV an exciting company to watch. In February, PNTV uplisted to the OTCQB Venture Market and paid down most of its outstanding debt. While PNTV says it has always been fully reporting, moving to the OTCQB increases…

Continue Reading

TuesdayJun 13, 2017 1:29 pm

ChineseInvestors.com, Inc. (CIIX) Participates In SeeThruEquity Microcap Investor Conference, Receives Research Report Confidence in its Cannabis Market Penetration and Growth

ChineseInvestors.com, Inc. (OTCQB: CIIX) participated in SeeThruEquity’s 6th Annual Microcap Investor Conference on June 1, 2017, in New York. That conference gives investors the exclusive opportunity to discover publicly traded companies with market capitalization of less than $1 billion. CIIX offers educational consulting services for Chinese investors. Most recently, it has been pursuing opportunities in the cannabis market. The goal of the company is to be a leading publicly-traded company within the nutritional industry. In addition to its online store based in the free trade zone of Shanghai, China, CIIX is building its first retail store in San Gabriel, California.…

Continue Reading

TuesdayJun 13, 2017 10:06 am

QualityStocksNewsBreaks – Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF) Reports Confirmed PATSCAN CMR™ Sales Commitments of $2.7M

Patriot One Technologies, Inc. (TSX.V: PAT) (OTCQB: PTOTF), developer of the award-winning PATSCAN CMR™ concealed weapons detection system, this morning announced that it has recorded $2.7 million in confirmed sales commitment since commencing product marketing just three months ago ahead of the ISC West trade show in Las Vegas. “Our roll-out program initially conceived finalizing our engineering in early spring in order to meet Industry Canada and FCC certification requirements by late summer,” Dinesh Kandanchatha, president and CTO of Patriot One, stated in the news release. “We have informed our supply chain partners of the accelerating demand, and I am…

Continue Reading

TuesdayJun 13, 2017 9:36 am

QualityStocksNewsBreaks – Converde Energy USA, Inc. (XFUL) Enters Securities Purchase Agreement with GPL Ventures LLC; Retains Minivest as Advisor

Converde Energy USA, Inc. (OTC: XFUL) this morning announced its entry into a securities purchase agreement with GPL Ventures LLC (“GPL”) through which GPL will have the option to purchase up to $3 million in XFUL common stock when the company has qualified the necessary number of shares under Regulation A through an offering statement. Per the update, XFUL intends to file the offering statement within the next 30 days. “We are very excited to have this investment agreement in place as a primary funding vehicle for the company,” Brad Domitrovitsch, chairman and CEO of XFUL, stated in the news…

Continue Reading

TuesdayJun 13, 2017 9:02 am

QualityStocksNewsBreaks – InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) Teams with Pharmaseed to Advance Development of INM-750

Preclinical stage biopharmaceutical company InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF) this morning announced its entry into an agreement with Pharmaseed Ltd., Israel’s largest GLP-certified pre-clinical contract research organization. Under the terms of this agreement, the Pharmaseed development team will now play a key role in the ongoing development of InMed’s lead compound, INM-750, which is a proprietary, topical cannabinoid product candidate that’s currently being studied as a therapy in epidermolysis bullosa and other potential dermatological and wound-healing applications. “This agreement with Pharmaseed now adds one of Israel's leading formulation development teams to our efforts and represents an important strategic…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered